High plasma levels of C1-inhibitor are associated with lower risk of future venous thromboembolism

Abstract

High plasma levels of C1INH were associated with lower risk of VTE, and C1INH inhibited thrombin generation initiated by the intrinsic coagulation pathway ex vivo.